Tag
OTCMKTS: RHHBY
- Novo Nordisk A/S says FDA extends denecimig review over facility remediation
- Surrozen gains FDA IND clearance for SZN‑8141 macular edema trial
- DBV Technologies submits peanut patch BLA for children aged 4 to 7
- Merck says remigromig met BRUNELLO vision endpoint, flags eye risks
- Ionis Pharmaceuticals' Phase 3 kidney trial meets proteinuria endpoint
- Early detection breakthrough means pancreatic cancer could be diagnosed in minutes
- TG Therapeutics stock spikes on strong financials and optimism for its flagship drug
- Poseida Therapeutics shares skyrocket on acquisition from pharma-giant Roche